166 related articles for article (PubMed ID: 15358619)
1. Both proteasomes and lysosomes degrade the activated erythropoietin receptor.
Walrafen P; Verdier F; Kadri Z; Chrétien S; Lacombe C; Mayeux P
Blood; 2005 Jan; 105(2):600-8. PubMed ID: 15358619
[TBL] [Abstract][Full Text] [Related]
2. Proteasomes regulate the duration of erythropoietin receptor activation by controlling down-regulation of cell surface receptors.
Verdier F; Walrafen P; Hubert N; Chretien S; Gisselbrecht S; Lacombe C; Mayeux P
J Biol Chem; 2000 Jun; 275(24):18375-81. PubMed ID: 10849444
[TBL] [Abstract][Full Text] [Related]
3. Activation of the erythropoietin receptor is not required for internalization of bound erythropoietin.
Beckman DL; Lin LL; Quinones ME; Longmore GD
Blood; 1999 Oct; 94(8):2667-75. PubMed ID: 10515870
[TBL] [Abstract][Full Text] [Related]
4. beta-Trcp mediates ubiquitination and degradation of the erythropoietin receptor and controls cell proliferation.
Meyer L; Deau B; Forejtníková H; Duménil D; Margottin-Goguet F; Lacombe C; Mayeux P; Verdier F
Blood; 2007 Jun; 109(12):5215-22. PubMed ID: 17327410
[TBL] [Abstract][Full Text] [Related]
5. Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation.
Bouscary D; Pene F; Claessens YE; Muller O; Chrétien S; Fontenay-Roupie M; Gisselbrecht S; Mayeux P; Lacombe C
Blood; 2003 May; 101(9):3436-43. PubMed ID: 12506011
[TBL] [Abstract][Full Text] [Related]
6. Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways.
Tong W; Zhang J; Lodish HF
Blood; 2005 Jun; 105(12):4604-12. PubMed ID: 15705783
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietin hypersensitivity in primary familial and congenital polycythemia: role of tyrosines Y285 and Y344 in erythropoietin receptor cytoplasmic domain.
Arcasoy MO; Karayal AF
Biochim Biophys Acta; 2005 Apr; 1740(1):17-28. PubMed ID: 15878737
[TBL] [Abstract][Full Text] [Related]
8. Activation and inhibition of the erythropoietin receptor by a membrane-anchored erythropoietin.
Negre O; Fusil F; Henri A; Villette JM; Leboulch P; Beuzard Y; Payen E
Exp Hematol; 2008 Apr; 36(4):412-23. PubMed ID: 18295963
[TBL] [Abstract][Full Text] [Related]
9. Cellular trafficking and degradation of erythropoietin and novel erythropoiesis stimulating protein (NESP).
Gross AW; Lodish HF
J Biol Chem; 2006 Jan; 281(4):2024-32. PubMed ID: 16286456
[TBL] [Abstract][Full Text] [Related]
10. Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation.
Livnah O; Stura EA; Middleton SA; Johnson DL; Jolliffe LK; Wilson IA
Science; 1999 Feb; 283(5404):987-90. PubMed ID: 9974392
[TBL] [Abstract][Full Text] [Related]
11. Co-stimulation with stem cell factor and erythropoietin enhances migration of c-Kit expressing cervical cancer cells through the sustained activation of ERK1/2.
Aguilar C; Aguilar C; Lopez-Marure R; Jiménez-Sánchez A; Rocha-Zavaleta L
Mol Med Rep; 2014 May; 9(5):1895-902. PubMed ID: 24626629
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin ameliorates early brain injury after subarachnoid haemorrhage by modulating microglia polarization via the EPOR/JAK2-STAT3 pathway.
Wei S; Luo C; Yu S; Gao J; Liu C; Wei Z; Zhang Z; Wei L; Yi B
Exp Cell Res; 2017 Dec; 361(2):342-352. PubMed ID: 29102603
[TBL] [Abstract][Full Text] [Related]
13. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin.
Witthuhn BA; Quelle FW; Silvennoinen O; Yi T; Tang B; Miura O; Ihle JN
Cell; 1993 Jul; 74(2):227-36. PubMed ID: 8343951
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the Asymmetry of Activated EPO Receptor Enables Designing Small Molecule Agonists.
Guarnieri F
Vitam Horm; 2017; 105():19-37. PubMed ID: 28629518
[TBL] [Abstract][Full Text] [Related]
15. Cbl negatively regulates erythropoietin-induced growth and survival signaling through the proteasomal degradation of Src kinase.
Shintani T; Ohara-Waki F; Kitanaka A; Tanaka T; Kubota Y
Blood Cells Mol Dis; 2014 Dec; 53(4):211-8. PubMed ID: 25084697
[TBL] [Abstract][Full Text] [Related]
16. A human erythropoietin receptor gene mutant causing familial erythrocytosis is associated with deregulation of the rates of Jak2 and Stat5 inactivation.
Arcasoy MO; Harris KW; Forget BG
Exp Hematol; 1999 Jan; 27(1):63-74. PubMed ID: 9923445
[TBL] [Abstract][Full Text] [Related]
17. β Common receptor integrates the erythropoietin signaling in activation of endothelial nitric oxide synthase.
Su KH; Shyue SK; Kou YR; Ching LC; Chiang AN; Yu YB; Chen CY; Pan CC; Lee TS
J Cell Physiol; 2011 Dec; 226(12):3330-9. PubMed ID: 21321940
[TBL] [Abstract][Full Text] [Related]
18. Polycythaemia-inducing mutations in the erythropoietin receptor (EPOR): mechanism and function as elucidated by epidermal growth factor receptor-EPOR chimeras.
Gross M; Ben-Califa N; McMullin MF; Percy MJ; Bento C; Cario H; Minkov M; Neumann D
Br J Haematol; 2014 May; 165(4):519-28. PubMed ID: 24533580
[TBL] [Abstract][Full Text] [Related]
19. Changes in conformation and stability upon formation of complexes of erythropoietin (EPO) and soluble EPO receptor.
Narhi LO; Aoki KH; Philo JS; Arakawa T
J Protein Chem; 1997 Apr; 16(3):213-25. PubMed ID: 9155092
[TBL] [Abstract][Full Text] [Related]
20. Localization of an essential ligand binding determinant of the human erythropoietin receptor to a domain N-terminal to the WSXWS motif: implications for soluble receptor function.
Schimmenti LA; Blechert G; Harris KW; Winkelmann JC
Exp Hematol; 1995 Dec; 23(13):1341-6. PubMed ID: 7498361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
